Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1981-08-24
1983-08-02
Bleutge, John C.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
424 85, 424101, 260112B, C08L 8900
Patent
active
043966080
ABSTRACT:
A composition is disclosed which comprises a solution in a pharmaceutically acceptable carrier of an immune serum globulin, said solution having an ionic strength and a pH to maintain the monomer content and the actual and latent anticomplement activity of the immune serum globulin such that the composition is intravenously injectable. Novel methods are disclosed for preparing the above composition.
REFERENCES:
patent: 4093606 (1978-06-01), Coval
patent: 4186192 (1980-01-01), Lundblad
Bleutge John C.
Cutter Laboratories
Leitereg Theodore J.
Short Patricia
LandOfFree
Intravenously injectable immune serum globulin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intravenously injectable immune serum globulin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intravenously injectable immune serum globulin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-483759